DaVita (NYS: DVA) reported earnings on Feb. 16. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), DaVita met expectations on revenues and beat expectations on earnings per share.
Compared with the prior-year quarter, revenue grew and GAAP earnings per share expanded significantly.
Margins grew across the board.
DaVita reported revenue of $1.86 billion. The 14 analysts polled by S&P Capital IQ expected a top line of $1.85 billion on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $1.65 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $1.58. The 16 earnings estimates compiled by S&P Capital IQ forecast $1.49 per share on the same basis. GAAP EPS of $1.57 for Q4 were 121% higher than the prior-year quarter's $0.71 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 34.8%, 360 basis points better than the prior-year quarter. Operating margin was 17.6%, 220 basis points better than the prior-year quarter. Net margin was 8.0%, 380 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.85 billion. On the bottom line, the average EPS estimate is $1.45.
Next year's average estimate for revenue is $7.68 billion. The average EPS estimate is $6.24.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 240 members out of 253 rating the stock outperform, and 13 members rating it underperform. Among 83 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 82 give DaVita a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DaVita is outperform, with an average price target of $85.72.
If you're interested in health-care stocks like DaVita, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Get instant access to this free report.
Add DaVita to My Watchlist.
At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings. He is the co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.